Prevalence of Amlodipine-induced Gingival Overgrowth

DOI Web Site 4 Citations 31 References Open Access
  • Tanaka Shigeo
    Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo
  • Ono Makiko
    Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo
  • Matsumoto Hiroko
    Departments of Oral Molecular Pharmacology, Nihon University School of Dentistry at Matsudo
  • Takeuchi Reiri
    Departments of Oral Molecular Pharmacology, Nihon University School of Dentistry at Matsudo
  • Okada Hiroyuki
    Departments of Pathology, Nihon University School of Dentistry at Matsudo
  • Yamamoto Hirotsugu
    Departments of Pathology, Nihon University School of Dentistry at Matsudo
  • Makiyama Yasuhide
    Departments of Head and Neck Surgery, Nihon University School of Dentistry at Matsudo
  • Akimoto Yoshiaki
    Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo
  • Hirayama Teruyasu
    Departments of Neurological Surgery, Nihon University School of Dentistry at Matsudo
  • Fujii Akira
    University Research Center, Nihon University
  • Sakamaki Tatsuo
    Departments of Internal Medicine, Nihon University School of Dentistry at Matsudo

Bibliographic Information

Published
2010
DOI
  • 10.5466/ijoms.9.96
Publisher
Research Institute of Oral Science, Nihon University School of Dentistry at Matsudo

Search this article

Description

The prevalence rate of amlodipine-induced gingival overgrowth was determined in patients taking amlodipine for three months. Gingival overgrowth was found in four cases among the 301 patients surveyed ; a prevalence rate of 1.3%. The clinical findings of amlodipine-induced gingival overgrowth were similar to those induced by other calcium channel blockers.

Journal

Citations (4)*help

See more

References(31)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top